{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T17:49:56Z","timestamp":1791395396051,"version":"4.3.3"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s12328-020-01171-y","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T08:03:46Z","timestamp":1594195426000},"page":"650-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Current evidence and issues of endoscopic submucosal dissection for gastric neoplasms during antithrombotic therapy"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4717-5196","authenticated-orcid":false,"given":"Yoshiyasu","family":"Kono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Issei","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisahiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsu","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiro","family":"Gotoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Moritou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"1171_CR1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s00464-012-2555-2","volume":"27","author":"T Toyonaga","year":"2013","unstructured":"Toyonaga T, Man-i M, East JE, et al. 1,635 Endoscopic submucosal dissection cases in the esophagus, stomach, and colorectum: complication rates and long-term outcomes. Surg Endosc. 2013;27:1000\u20138.","journal-title":"Surg Endosc"},{"key":"1171_CR2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/den.12099","volume":"26","author":"T Kosaka","year":"2014","unstructured":"Kosaka T, Endo M, Toya Y, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a single-center retrospective study. Dig Endosc. 2014;26:183\u201391.","journal-title":"Dig Endosc"},{"key":"1171_CR3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10120-016-0664-7","volume":"20","author":"S Tanabe","year":"2017","unstructured":"Tanabe S, Ishido K, Matsumoto T, et al. Long-term outcomes of endoscopic submucosal dissection for early gastric cancer: a multicenter collaborative study. Gastr Cancer. 2017;20:45\u201352.","journal-title":"Gastr Cancer"},{"key":"1171_CR4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/PL00011720","volume":"3","author":"T Gotoda","year":"2000","unstructured":"Gotoda T, Yanagisawa A, Sasako M, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastr Cancer. 2000;3:219\u201325.","journal-title":"Gastr Cancer"},{"key":"1171_CR5","doi-asserted-by":"crossref","unstructured":"Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1\u201319.","DOI":"10.1007\/s10120-016-0622-4"},{"key":"1171_CR6","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.gie.2016.06.033","volume":"84","author":"D Libanio","year":"2016","unstructured":"Libanio D, Costa MN, Pimentel-Nunes P, et al. Risk factors for bleeding after gastric endoscopic submucosal dissection: a systematic review and meta-analysis. Gastrointest Endosc. 2016;84:572\u201386.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/den.13246","volume":"31","author":"H Suzuki","year":"2019","unstructured":"Suzuki H, Takizawa K, Hirasawa T, et al. Short-term outcomes of multicenter prospective cohort study of gastric endoscopic resection: 'Real-world evidence' in Japan. Dig Endosc. 2019;31:30\u20139.","journal-title":"Dig Endosc"},{"key":"1171_CR8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.gie.2013.03.008","volume":"78","author":"R Koh","year":"2013","unstructured":"Koh R, Hirasawa K, Yahara S, et al. Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms. Gastrointest Endosc. 2013;78:476\u201383.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1055\/s-0038-1648843","volume":"72","author":"G Palareti","year":"1994","unstructured":"Palareti G, Legnani C, Guazzaloca G, et al. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants\u2014a prospective study. Thromb Haemost. 1994;72:222\u20136.","journal-title":"Thromb Haemost"},{"key":"1171_CR10","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/archinte.158.15.1610","volume":"158","author":"MJ Wahl","year":"1998","unstructured":"Wahl MJ. Dental surgery in anticoagulated patients. Arch Intern Med. 1998;158:1610\u20136.","journal-title":"Arch Intern Med"},{"key":"1171_CR11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/archneur.62.8.1217","volume":"62","author":"AB Maulaz","year":"2005","unstructured":"Maulaz AB, Bezerra DC, Michel P, et al. Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch Neurol. 2005;62:1217\u201320.","journal-title":"Arch Neurol"},{"key":"1171_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-152-1-201001050-00179","volume":"152","author":"JJ Sung","year":"2010","unstructured":"Sung JJ, Lau JY, Ching JY, et al. Continuation of low-dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med. 2010;152:1\u20139.","journal-title":"Ann Intern Med"},{"key":"1171_CR13","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1001\/archinternmed.2012.4261","volume":"172","author":"DM Witt","year":"2012","unstructured":"Witt DM, Delate T, Garcia DA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med. 2012;172:1484\u201391.","journal-title":"Arch Intern Med"},{"key":"1171_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/den.12183","volume":"26","author":"K Fujimoto","year":"2014","unstructured":"Fujimoto K, Fujishiro M, Kato M, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc. 2014;26:1\u201314.","journal-title":"Dig Endosc"},{"key":"1171_CR15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gie.2015.09.035","volume":"83","author":"RD Acosta","year":"2016","unstructured":"Acosta RD, Abraham NS, Chandrasekhara V, et al. The management of antithrombotic agents for patients undergoing GI endoscopy. Gastrointest Endosc. 2016;83:3\u201316.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/gutjnl-2015-311110","volume":"65","author":"AM Veitch","year":"2016","unstructured":"Veitch AM, Vanbiervliet G, Gershlick AH, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines. Gut. 2016;65:374\u201389.","journal-title":"Gut"},{"key":"1171_CR17","first-page":"39","volume":"14","author":"MF Suri","year":"2008","unstructured":"Suri MF, Hussein HM, Abdelmoula MM, et al. Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience. Med Sci Monit. 2008;14:39\u201344.","journal-title":"Med Sci Monit"},{"key":"1171_CR18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018;39:213\u201360.","journal-title":"Eur Heart J"},{"key":"1171_CR19","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.1161\/STROKEAHA.118.022606","volume":"50","author":"WJ Powers","year":"2019","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2019;50:e344\u2013e418.","journal-title":"Stroke"},{"key":"1171_CR20","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1001\/jama.2019.7025","volume":"321","author":"KM Ziada","year":"2019","unstructured":"Ziada KM, Moliterno DJ. Dual antiplatelet therapy: is it time to cut the cord with aspirin? JAMA. 2019;321:2409\u201311.","journal-title":"JAMA"},{"key":"1171_CR21","first-page":"20","volume":"20","author":"B Wernly","year":"2019","unstructured":"Wernly B, Rezar R, Gurbel P, et al. Short-term dual antiplatelet therapy (DAPT) followed by P2Y12 monotherapy versus traditional DAPT in patients undergoing percutaneous coronary intervention: meta-analysis and viewpoint. J Thromb Thrombolysis. 2019;20:20.","journal-title":"J Thromb Thrombolysis"},{"key":"1171_CR22","first-page":"1607181","volume":"20","author":"M Paciaroni","year":"2019","unstructured":"Paciaroni M, Ince B, Hu B, et al. Benefits and risks of clopidogrel vs aspirin monotherapy after recent ischemic stroke: a systematic review and meta-analysis. Cardiovasc Ther. 2019;20:1607181.","journal-title":"Cardiovasc Ther"},{"key":"1171_CR23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263\u201372.","journal-title":"Chest"},{"key":"1171_CR24","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893\u2013962.","journal-title":"Eur Heart J"},{"key":"1171_CR25","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/j.hrthm.2019.01.024","volume":"16","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm. 2019;16:e66\u2013e93.","journal-title":"Heart Rhythm"},{"key":"1171_CR26","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E, et al. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955\u201362.","journal-title":"Lancet"},{"key":"1171_CR27","doi-asserted-by":"crossref","first-page":"e0144856","DOI":"10.1371\/journal.pone.0144856","volume":"10","author":"AT Cohen","year":"2015","unstructured":"Cohen AT, Hamilton M, Mitchell SA, et al. Comparison of the novel oral anticoagulants apixaban, dabigatran, edoxaban, and rivaroxaban in the initial and long-term treatment and prevention of venous thromboembolism: systematic review and network meta-analysis. PLoS\u00a0One. 2015;10:e0144856.","journal-title":"PLoS\u00a0One"},{"key":"1171_CR28","first-page":"365830","volume":"20","author":"T Yoshio","year":"2013","unstructured":"Yoshio T, Nishida T, Kawai N, et al. Gastric ESD under heparin replacement at high-risk patients of thromboembolism is technically feasible but has a high risk of delayed bleeding: Osaka University ESD Study Group. Gastroenterol Res Pract. 2013;20:365830.","journal-title":"Gastroenterol Res Pract"},{"key":"1171_CR29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1186\/1471-230X-14-172","volume":"14","author":"T Matsumura","year":"2014","unstructured":"Matsumura T, Arai M, Maruoka D, et al. Risk factors for early and delayed post-operative bleeding after endoscopic submucosal dissection of gastric neoplasms, including patients with continued use of antithrombotic agents. BMC Gastroenterol. 2014;14:172.","journal-title":"BMC Gastroenterol"},{"key":"1171_CR30","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12029-017-0049-0","volume":"49","author":"V Jaruvongvanich","year":"2018","unstructured":"Jaruvongvanich V, Sempokuya T, Wijarnpreecha K, et al. Heparin-bridging therapy and risk of bleeding after endoscopic submucosal dissection for gastric neoplasms: a meta-analysis. J Gastrointest Cancer. 2018;49:16\u201320.","journal-title":"J Gastrointest Cancer"},{"key":"1171_CR31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/den.13184","volume":"30","author":"M Kato","year":"2018","unstructured":"Kato M, Uedo N, Hokimoto S, et al. Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment: 2017 appendix on anticoagulants including direct oral anticoagulants. Dig Endosc. 2018;30:433\u201340.","journal-title":"Dig Endosc"},{"key":"1171_CR32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1055\/s-0031-1291459","volume":"44","author":"SJ Cho","year":"2012","unstructured":"Cho SJ, Choi IJ, Kim CG, et al. Aspirin use and bleeding risk after endoscopic submucosal dissection in patients with gastric neoplasms. Endoscopy. 2012;44:114\u201321.","journal-title":"Endoscopy"},{"key":"1171_CR33","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.gie.2011.11.034","volume":"75","author":"JH Lim","year":"2012","unstructured":"Lim JH, Kim SG, Kim JW, et al. Do antiplatelets increase the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms? Gastrointest Endosc. 2012;75:719\u201327.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10120-013-0305-3","volume":"17","author":"Y Sanomura","year":"2014","unstructured":"Sanomura Y, Oka S, Tanaka S, et al. Continued use of low-dose aspirin does not increase the risk of bleeding during or after endoscopic submucosal dissection for early gastric cancer. Gastr Cancer. 2014;17:489\u201396.","journal-title":"Gastr Cancer"},{"key":"1171_CR35","first-page":"E31","volume":"3","author":"S Tounou","year":"2015","unstructured":"Tounou S, Morita Y, Hosono T. Continuous aspirin use does not increase post-endoscopic dissection bleeding risk for gastric neoplasms in patients on antiplatelet therapy. Endosc Int Open. 2015;3:E31\u2013E3838.","journal-title":"Endosc Int Open"},{"key":"1171_CR36","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1007\/s00464-016-5167-4","volume":"31","author":"K Igarashi","year":"2017","unstructured":"Igarashi K, Takizawa K, Kakushima N, et al. Should antithrombotic therapy be stopped in patients undergoing gastric endoscopic submucosal dissection? Surg Endosc. 2017;31:1746\u201353.","journal-title":"Surg Endosc"},{"key":"1171_CR37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/jgh.13872","volume":"33","author":"Y Kono","year":"2018","unstructured":"Kono Y, Obayashi Y, Baba Y, et al. Postoperative bleeding risk after gastric endoscopic submucosal dissection during antithrombotic drug therapy. J Gastroenterol Hepatol. 2018;33:453\u201360.","journal-title":"J Gastroenterol Hepatol"},{"key":"1171_CR38","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3748\/wjg.v25.i4.457","volume":"25","author":"H Harada","year":"2019","unstructured":"Harada H, Suehiro S, Murakami D, et al. Feasibility of gastric endoscopic submucosal dissection with continuous low-dose aspirin for patients receiving dual antiplatelet therapy. World J Gastroenterol. 2019;25:457\u201368.","journal-title":"World J Gastroenterol"},{"key":"1171_CR39","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.gie.2017.07.017","volume":"86","author":"J Dong","year":"2017","unstructured":"Dong J, Wei K, Deng J, et al. Effects of antithrombotic therapy on bleeding after endoscopic submucosal dissection. Gastrointest Endosc. 2017;86:807\u201316.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR40","first-page":"344","volume":"31","author":"V Jaruvongvanich","year":"2018","unstructured":"Jaruvongvanich V, Sempokuya T, Wijarnpreecha K, et al. Continued versus interrupted aspirin use and bleeding risk after endoscopic submucosal dissection of gastric neoplasms: a meta-analysis. Ann Gastroenterol. 2018;31:344\u20139.","journal-title":"Ann Gastroenterol"},{"issue":"277\u201385","key":"1171_CR41","first-page":"e2","volume":"89","author":"S So","year":"2019","unstructured":"So S, Ahn JY, Kim N, et al. Comparison of the effects of antithrombotic therapy on delayed bleeding after gastric endoscopic resection: a propensity score-matched case\u2013control study. Gastrointest Endosc. 2019;89(277\u201385):e2.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR42","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5009\/gnl17384","volume":"12","author":"S Oh","year":"2018","unstructured":"Oh S, Kim SG, Kim J, et al. Continuous use of thienopyridine may be as safe as low-dose aspirin in endoscopic resection of gastric tumors. Gut Liver. 2018;12:393\u2013401.","journal-title":"Gut Liver"},{"key":"1171_CR43","doi-asserted-by":"crossref","first-page":"E943","DOI":"10.1055\/s-0043-116381","volume":"5","author":"S Ono","year":"2017","unstructured":"Ono S, Myojo M, Harada H, et al. Is it possible to perform gastric endoscopic submucosal dissection without discontinuation of a single antiplatelet of thienopyridine derivatives? Endosc Int Open. 2017;5:E943\u2013E949949.","journal-title":"Endosc Int Open"},{"key":"1171_CR44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.4253\/wjge.v8.i7.349","volume":"8","author":"Y Shindo","year":"2016","unstructured":"Shindo Y, Matsumoto S, Miyatani H, et al. Risk factors for postoperative bleeding after gastric endoscopic submucosal dissection in patients under antithrombotics. World J Gastrointest Endosc. 2016;8:349\u201356.","journal-title":"World J Gastrointest Endosc"},{"key":"1171_CR45","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10120-015-0588-7","volume":"20","author":"T Furuhata","year":"2017","unstructured":"Furuhata T, Kaise M, Hoteya S, et al. Postoperative bleeding after gastric endoscopic submucosal dissection in patients receiving antithrombotic therapy. Gastr Cancer. 2017;20:207\u201314.","journal-title":"Gastr Cancer"},{"key":"1171_CR46","doi-asserted-by":"crossref","first-page":"E653","DOI":"10.1055\/s-0043-110050","volume":"5","author":"T Gotoda","year":"2017","unstructured":"Gotoda T, Hori K, Iwamuro M, et al. Evaluation of the bleeding risk with various antithrombotic therapies after gastric endoscopic submucosal dissection. Endosc Int Open. 2017;5:E653\u2013E662662.","journal-title":"Endosc Int Open"},{"key":"1171_CR47","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.3748\/wjg.v23.i30.5557","volume":"23","author":"C Sato","year":"2017","unstructured":"Sato C, Hirasawa K, Koh R, et al. Postoperative bleeding in patients on antithrombotic therapy after gastric endoscopic submucosal dissection. World J Gastroenterol. 2017;23:5557\u201366.","journal-title":"World J Gastroenterol"},{"key":"1171_CR48","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/den.12859","volume":"29","author":"T Yoshio","year":"2017","unstructured":"Yoshio T, Tomida H, Iwasaki R, et al. Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection. Dig Endosc. 2017;29:686\u201394.","journal-title":"Dig Endosc"},{"key":"1171_CR49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000485026","volume":"97","author":"Y Sanomura","year":"2018","unstructured":"Sanomura Y, Oka S, Tanaka S, et al. Taking warfarin with heparin replacement and direct oral anticoagulant is a risk factor for bleeding after endoscopic submucosal dissection for early gastric cancer. Digestion. 2018;97:240\u20139.","journal-title":"Digestion"},{"key":"1171_CR50","doi-asserted-by":"crossref","unstructured":"Toya Y, Endo M, Oizumi T, et al. Risk Factors for Post-gastric Endoscopic Submucosal Dissection Bleeding with a Special Emphasis on Anticoagulant Therapy. Dig Dis Sci. 2019; 20:20.","DOI":"10.1007\/s10620-019-05776-3"},{"key":"1171_CR51","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1501035","volume":"373","author":"JD Douketis","year":"2015","unstructured":"Douketis JD, Spyropoulos AC, Kaatz S, et al. Perioperative bridging anticoagulation in patients with atrial fibrillation. N Engl J Med. 2015;373:823\u201333.","journal-title":"N Engl J Med"},{"key":"1171_CR52","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1136\/gutjnl-2017-313999","volume":"67","author":"N Nagata","year":"2018","unstructured":"Nagata N, Yasunaga H, Matsui H, et al. Therapeutic endoscopy-related GI bleeding and thromboembolic events in patients using warfarin or direct oral anticoagulants: results from a large nationwide database analysis. Gut. 2018;67:1805\u201312.","journal-title":"Gut"},{"key":"1171_CR53","doi-asserted-by":"crossref","first-page":"E348","DOI":"10.1055\/s-0043-105493","volume":"5","author":"H Harada","year":"2017","unstructured":"Harada H, Suehiro S, Murakami D, et al. Continuous use of low-dose warfarin for gastric endoscopic submucosal dissection: a prospective study. Endosc Int Open. 2017;5:E348\u2013E353353.","journal-title":"Endosc Int Open"},{"key":"1171_CR54","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.2169\/internalmedicine.2754-19","volume":"58","author":"N Kakushima","year":"2019","unstructured":"Kakushima N, Ono H, Takizawa K, et al. Incidence of delayed bleeding among patients continuing antithrombotics during gastric endoscopic submucosal dissection. Intern Med. 2019;58:2759\u201366.","journal-title":"Intern Med"},{"key":"1171_CR55","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/apt.13747","volume":"44","author":"T Kagawa","year":"2016","unstructured":"Kagawa T, Iwamuro M, Ishikawa S, et al. Vonoprazan prevents bleeding from endoscopic submucosal dissection-induced gastric ulcers. Aliment Pharmacol Ther. 2016;44:583\u201391.","journal-title":"Aliment Pharmacol Ther"},{"key":"1171_CR56","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.gie.2014.08.028","volume":"81","author":"Y Tsuji","year":"2015","unstructured":"Tsuji Y, Fujishiro M, Kodashima S, et al. Polyglycolic acid sheets and fibrin glue decrease the risk of bleeding after endoscopic submucosal dissection of gastric neoplasms (with video). Gastrointest Endosc. 2015;81:906\u201312.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR57","first-page":"1457357","volume":"20","author":"H Fukuda","year":"2016","unstructured":"Fukuda H, Yamaguchi N, Isomoto H, et al. Polyglycolic acid felt sealing method for prevention of bleeding related to endoscopic submucosal dissection in patients taking antithrombotic agents. Gastroenterol Res Pract. 2016;20:1457357.","journal-title":"Gastroenterol Res Pract."},{"key":"1171_CR58","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.gie.2015.11.015","volume":"83","author":"T Uraoka","year":"2016","unstructured":"Uraoka T, Ochiai Y, Fujimoto A, et al. A novel fully synthetic and self-assembled peptide solution for endoscopic submucosal dissection-induced ulcer in the stomach. Gastrointest Endosc. 2016;83:1259\u201364.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR59","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/s10120-018-0791-4","volume":"21","author":"N Kawata","year":"2018","unstructured":"Kawata N, Ono H, Takizawa K, et al. Efficacy of polyglycolic acid sheets and fibrin glue for prevention of bleeding after gastric endoscopic submucosal dissection in patients under continued antithrombotic agents. Gastric Cancer. 2018;21:696\u2013702.","journal-title":"Gastric Cancer"},{"key":"1171_CR60","first-page":"2174957","volume":"20","author":"D Kikuchi","year":"2018","unstructured":"Kikuchi D, Iizuka T, Nomura K, et al. Feasibility of autologous fibrin glue and polyglycolic acid sheets to prevent delayed bleeding after endoscopic submucosal dissection of gastric neoplasms in patients receiving antithrombotic therapy. Gastroenterol Res Pract. 2018;20:2174957.","journal-title":"Gastroenterol Res Pract."},{"key":"1171_CR61","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1007\/s00464-017-6019-6","volume":"32","author":"H Mori","year":"2018","unstructured":"Mori H, Guan Y, Kobara H, et al. Efficacy of innovative polyglycolic acid sheet device delivery station system: a randomized prospective study. Surg Endosc. 2018;32:3076\u201386.","journal-title":"Surg Endosc"},{"key":"1171_CR62","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/a-0860-5280","volume":"51","author":"Y Kataoka","year":"2019","unstructured":"Kataoka Y, Tsuji Y, Hirasawa K, et al. Endoscopic tissue shielding to prevent bleeding after endoscopic submucosal dissection: a prospective multicenter randomized controlled trial. Endoscopy. 2019;51:619\u201327.","journal-title":"Endoscopy"},{"key":"1171_CR63","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.gie.2013.02.008","volume":"78","author":"HY Ryu","year":"2013","unstructured":"Ryu HY, Kim JW, Kim HS, et al. Second-look endoscopy is not associated with better clinical outcomes after gastric endoscopic submucosal dissection: a prospective, randomized, clinical trial analyzed on an as-treated basis. Gastrointest Endosc. 2013;78:285\u201394.","journal-title":"Gastrointest Endosc"},{"key":"1171_CR64","doi-asserted-by":"crossref","first-page":"480","DOI":"10.5009\/gnl13226","volume":"8","author":"JS Kim","year":"2014","unstructured":"Kim JS, Chung MW, Chung CY, et al. The need for second-look endoscopy to prevent delayed bleeding after endoscopic submucosal dissection for gastric neoplasms: a prospective randomized trial. Gut Liver. 2014;8:480\u20136.","journal-title":"Gut Liver"},{"key":"1171_CR65","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/gutjnl-2014-307552","volume":"64","author":"S Mochizuki","year":"2015","unstructured":"Mochizuki S, Uedo N, Oda I, et al. Scheduled second-look endoscopy is not recommended after endoscopic submucosal dissection for gastric neoplasms (the SAFE trial): a multicentre prospective randomised controlled non-inferiority trial. Gut. 2015;64:397\u2013405.","journal-title":"Gut"},{"key":"1171_CR66","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1007\/s10620-015-3693-x","volume":"60","author":"S Na","year":"2015","unstructured":"Na S, Ahn JY, Choi KD, et al. Delayed bleeding rate according to the forrest classification in second-look endoscopy after endoscopic submucosal dissection. Dig Dis Sci. 2015;60:3108\u201317.","journal-title":"Dig Dis Sci"},{"key":"1171_CR67","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/den.12410","volume":"27","author":"T Nishizawa","year":"2015","unstructured":"Nishizawa T, Suzuki H, Kinoshita S, et al. Second-look endoscopy after endoscopic submucosal dissection for gastric neoplasms. Dig Endosc. 2015;27:279\u201384.","journal-title":"Dig Endosc"},{"key":"1171_CR68","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MEG.0000000000000586","volume":"28","author":"SR Jee","year":"2016","unstructured":"Jee SR, Park MI, Lim SK, et al. Clinical impact of second-look endoscopy after endoscopic submucosal dissection of gastric neoplasm: a multicenter prospective randomized-controlled trial. Eur J Gastroenterol Hepatol. 2016;28:546\u201352.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1171_CR69","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jgh.13623","volume":"32","author":"EH Kim","year":"2017","unstructured":"Kim EH, Park SW, Nam E, et al. Role of second-look endoscopy and prophylactic hemostasis after gastric endoscopic submucosal dissection: a systematic review and meta-analysis. J Gastroenterol Hepatol. 2017;32:756\u201368.","journal-title":"J Gastroenterol Hepatol"},{"key":"1171_CR70","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s10120-018-0878-y","volume":"22","author":"M Azumi","year":"2019","unstructured":"Azumi M, Takeuchi M, Koseki Y, et al. The search, coagulation, and clipping (SCC) method prevents delayed bleeding after gastric endoscopic submucosal dissection. Gastric Cancer. 2019;22:567\u201375.","journal-title":"Gastric Cancer"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01171-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-020-01171-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-020-01171-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,8]],"date-time":"2021-07-08T00:01:33Z","timestamp":1625702493000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-020-01171-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":70,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1171"],"URL":"https:\/\/doi.org\/10.1007\/s12328-020-01171-y","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Yoshiyasu Kono, Issei Hirata, Tetsuya Katayama, Hisahiro Uemura, Tetsu Hirata, Tatsuhiro Gotoda, Koji Miyahara, Yuki Moritou and Masahiro Nakagawa declare that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}